Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.14 Insider Own2.77% Shs Outstand5.21M Perf Week-2.50%
Market Cap13.64M Forward P/E- EPS next Y-1.67 Insider Trans0.00% Shs Float5.17M Perf Month2.98%
Income-16.30M PEG- EPS next Q-0.47 Inst Own9.48% Short Float / Ratio2.98% / 9.25 Perf Quarter-31.62%
Sales0.05M P/S272.83 EPS this Y-35.29% Inst Trans-65.34% Short Interest0.15M Perf Half Y-40.37%
Book/sh4.23 P/B0.61 EPS next Y44.15% ROA-50.80% Target Price33.00 Perf Year-63.33%
Cash/sh4.48 P/C0.57 EPS next 5Y- ROE-54.21% 52W Range2.31 - 10.33 Perf YTD-62.08%
Dividend- P/FCF- EPS past 5Y35.02% ROI-72.50% 52W High-75.18% Beta1.07
Dividend %- Quick Ratio10.98 Sales past 5Y-51.67% Gross Margin57.75% 52W Low11.00% ATR0.17
Employees17 Current Ratio10.98 Sales Q/Q- Oper. Margin-26871.14% RSI (14)48.74 Volatility3.45% 7.32%
OptionableNo Debt/Eq0.00 EPS Q/Q-174.67% Profit Margin-29641.28% Rel Volume0.40 Prev Close2.60
ShortableYes LT Debt/Eq0.00 EarningsNov 08 BMO Payout- Avg Volume16.66K Price2.56
Recom1.00 SMA20-0.00% SMA50-2.36% SMA200-39.89% Volume6,601 Change-1.50%
Date Action Analyst Rating Change Price Target Change
Jun-24-21Initiated Cantor Fitzgerald Overweight $3
Dec-10-20Upgrade Ladenburg Thalmann Neutral → Buy $3
Jan-12-18Reiterated H.C. Wainwright Buy $10 → $3
Jan-11-18Downgrade Canaccord Genuity Buy → Hold $11 → $2
Dec-08-17Resumed H.C. Wainwright Buy $10
Oct-07-16Initiated H.C. Wainwright Buy $25
Jul-22-15Initiated ROTH Capital Buy $36
Jun-23-15Initiated Canaccord Genuity Buy $15
Nov-13-23 02:45PM
Nov-08-23 08:17AM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
07:00PM Loading…
Oct-23-23 07:00PM
Sep-19-23 04:05PM
Aug-16-23 06:02AM
Aug-10-23 08:09AM
Jul-31-23 06:13AM
Jul-27-23 06:30AM
Jun-14-23 08:00AM
Jun-07-23 08:00AM
May-19-23 09:14AM
07:00AM Loading…
May-16-23 07:00AM
May-11-23 06:23AM
Apr-03-23 08:00AM
Mar-16-23 06:00AM
Mar-10-23 08:30AM
Jan-16-23 08:06AM
Jan-05-23 08:00AM
Dec-19-22 08:00AM
Nov-30-22 04:28AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-11-22 08:00AM
Sep-27-22 01:21PM
11:39AM Loading…
Sep-26-22 11:39AM
Sep-22-22 04:10PM
Sep-15-22 08:00AM
Aug-10-22 06:04AM
Aug-09-22 06:41AM
Aug-08-22 08:00AM
Jul-11-22 08:00AM
Jun-14-22 08:00AM
Jun-06-22 04:00PM
May-20-22 07:12AM
May-12-22 10:55AM
May-10-22 11:30AM
May-09-22 08:00AM
May-04-22 06:34AM
Apr-11-22 08:00AM
Mar-29-22 07:34PM
Mar-11-22 04:26AM
Mar-09-22 08:00AM
Mar-01-22 08:00AM
Feb-25-22 07:42AM
Feb-03-22 08:00AM
Jan-27-22 08:00AM
Jan-05-22 08:00AM
Dec-22-21 08:00AM
Nov-19-21 09:04AM
Nov-11-21 10:00AM
Nov-10-21 08:00AM
Nov-08-21 08:18AM
Nov-04-21 08:00AM
Nov-01-21 08:00AM
Oct-19-21 07:00AM
Oct-18-21 12:15PM
Oct-05-21 08:00AM
Sep-28-21 08:00AM
Sep-20-21 08:00AM
Sep-01-21 08:00AM
Aug-31-21 05:43AM
Aug-25-21 06:30AM
Aug-09-21 07:12AM
Aug-05-21 08:00AM
Jul-15-21 09:00AM
Jul-14-21 04:00PM
Jul-06-21 08:00AM
Jun-23-21 08:00AM
Jun-16-21 08:00AM
Jun-14-21 08:00AM
Jun-07-21 08:00AM
May-27-21 05:31AM
May-26-21 12:44PM
May-25-21 08:32PM
May-24-21 05:40AM
May-19-21 05:04AM
May-06-21 08:00AM
Mar-22-21 08:41AM
Mar-11-21 08:00AM
Mar-04-21 08:00AM
Mar-03-21 08:00AM
Feb-26-21 08:00AM
Jan-28-21 04:00PM
Jan-26-21 09:00AM
Jan-25-21 04:00PM
Jan-19-21 01:45PM
Jan-14-21 08:11AM
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mahesh V.CEO and PresidentMay 25Buy5.038,70643,791107,418May 25 03:10 PM
Patel Mahesh V.CEO and PresidentMar 24Buy0.32150,00048,0001,678,090Mar 24 05:28 PM
Ono Richard DanaDirectorMar 20Buy0.344,0001,36014,125Mar 20 06:51 PM
Patel Mahesh V.CEO and PresidentMar 17Buy0.3350,00016,5001,528,090Mar 17 04:31 PM